( >Copyright © 2007 PR Newswire Ass...)Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer,Health
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
MEDICINE
>>
TECHNOLOGY
Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer
Copyright © 2007 PR Newswire Association LLC. All rightsreserved. A United Business Media Company
http://www.bio-medicine.org/inc/biomed/medicine-technology.asp
http://feeds.bio-medicine.org/latest-medical-technology
> Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company
'"/>
Page:
1
2
3
4
5
6
7
8
9
Related medicine technology :
1
.
Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
2
.
Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
3
.
Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
4
.
Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
5
.
Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
6
.
Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
7
.
Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8
.
Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
9
.
Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10
.
YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11
.
Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
*
Name:
*
Comment:
*
Email:
TAG:
Data
Available
From
Erbitux
Phase
III
Study
First
Line
Treatment
Advanced
Lung
Cancer
Breaking Medicine Technology:
AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2
AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3
China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2
China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3
New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2
Fatigue common after myocardial infarction 48056 1
Fatigue common after myocardial infarction 48056 2
ASH and EHA jointly announce translational research training in hematology program 48053 1
ASH and EHA jointly announce translational research training in hematology program 48053 2
Medical Device Sterilization Seminar Offered by STERIS Isomedix Services 48051 1
Medical Device Sterilization Seminar Offered by STERIS Isomedix Services 48051 2
Medical Device Sterilization Seminar Offered by STERIS Isomedix Services 48051 3
[
0
] AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens
[
0
] China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
[
0
] New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies
Other Medicine Technology:
D1 Sports Training Facilities Adopt TurfAide(TM) Antimicrobial to New Synthetic Turf Fields from AstroTurf(R) 2
The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy 2
The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy 3
The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy 4
D1 Sports Training Facilities Adopt TurfAide(TM) Antimicrobial to New Synthetic Turf Fields from AstroTurf(R)
The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
Breaking Medicine News(10 mins):
Health News:Happy Feet are Healthy Feet: Common Sense Tips on Taking Care of Your Feet to Survive the Holiday Season 2
Health News:Kaiser Permanente Gives $5 Million to Children's Healthcare of Atlanta 2
Health News:Kaiser Permanente Gives $5 Million to Children's Healthcare of Atlanta 3
Health News:New research identifies modifiable risk factors for heart disease 2
Health News:New research identifies modifiable risk factors for heart disease 3
Health News:New research identifies modifiable risk factors for heart disease 4
Health News:New research identifies modifiable risk factors for heart disease 5
Health News:New research identifies modifiable risk factors for heart disease 6
Health News:Connecture, Inc. Launches New Technology Package to Increase Health Insurance Carriers' Success in the Online Individual Market 2
Health News:Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible 2
Health News:Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible 3
[
0
] Happy Feet are Healthy Feet: Common Sense Tips on Taking Care of Your Feet to Survive the Holiday Season
[
0
] Kaiser Permanente Gives $5 Million to Children's Healthcare of Atlanta
[
0
] New research identifies modifiable risk factors for heart disease
[
0
] Connecture, Inc. Launches New Technology Package to Increase Health Insurance Carriers' Success in the Online Individual Market
[
0
] Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible
Other Medicine News:
Health News:STERIS Isomedix Services Offers Gamma Engineering Run Program 2
Health News:Children Who Have Frequent Family Dinners Less Likely to Use Marijuana, Tobacco, and Drink Alcohol 2
Health News:Children Who Have Frequent Family Dinners Less Likely to Use Marijuana, Tobacco, and Drink Alcohol 3
Health News:Children Who Have Frequent Family Dinners Less Likely to Use Marijuana, Tobacco, and Drink Alcohol 4
Health News:Children Who Have Frequent Family Dinners Less Likely to Use Marijuana, Tobacco, and Drink Alcohol 5
Health News:UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics 2
Health News:Help for shopaholics: New test determines who's at risk for compulsive buying 2
Health News:The U.S. Surgeon General Issues National Call-to-Action on Deep-Vein Thrombosis (DVT) and Pulmonary Embolism (PE) 2
Health News:The U.S. Surgeon General Issues National Call-to-Action on Deep-Vein Thrombosis (DVT) and Pulmonary Embolism (PE) 3
Health News:The U.S. Surgeon General Issues National Call-to-Action on Deep-Vein Thrombosis (DVT) and Pulmonary Embolism (PE) 4
STERIS Isomedix Services Offers Gamma Engineering Run Program
Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference
Children Who Have Frequent Family Dinners Less Likely to Use Marijuana, Tobacco, and Drink Alcohol
UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics
Help for shopaholics: New test determines who's at risk for compulsive buying
The U.S. Surgeon General Issues National Call-to-Action on Deep-Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
Medicine Products:
Invacare Platinum XL 5-Liter Oxygen Concentrator
Invacare Platinum 10 Oxygen Concentrator
FreeStyle Portable Oxygen Concentrator
Millennium 5 Concentrator With or Without OPI
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health